Journal
FASEB JOURNAL
Volume 17, Issue 13, Pages 1789-1799Publisher
FEDERATION AMER SOC EXP BIOL
DOI: 10.1096/fj.02-0836com
Keywords
asthma; airway smooth muscle cells; sphingosine-1-phosphate; contractility
Categories
Funding
- NHLBI NIH HHS [HL67663, P01 HL067663, P50 HL067663] Funding Source: Medline
- NIAID NIH HHS [AI50094, R01 AI050094] Funding Source: Medline
Ask authors/readers for more resources
The bioactive sphingolipid sphingosine-1-phosphate (SIP) that is increased in airways of asthmatic subjects markedly induced contraction of human airway smooth muscle (HASM) cells embedded in collagen matrices in a G; independent manner. Dihydro-S1P, which binds to SIP receptors, also stimulated contractility. SIP induced formation of stress fibers, contraction of individual HASM cells, and stimulated myosin light chain phosphorylation, which was inhibited by the Rho-associated kinase inhibitor Y-27632. S1P-stimulated HASM cell contractility was independent of the ERK1/2 and PKC signaling pathways, important regulators of airway smooth muscle contraction. However, removal of extracellular calcium completely blocked S1P-mediated contraction and Y-27632 reduced it. SIP also induced calcium mobilization that was not desensitized by repeated additions. Pretreatment with thapsigargin to deplete InsP3 sensitive calcium stores partially blocked increases in [Ca2+](i) induced by SIP, yet did not inhibit S1P-stimulated contraction. In sharp contrast, the L-type calcium channel blocker verapamil markedly decreased S1P-induced HASM cell contraction, supporting a role for calcium influx from extracellular sources. Collectively, our results suggest that SIP may regulate HASM contractility, important in the pathobiology of asthma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available